Entacapone
Entacapone is a prescription medication used to treat Parkinson's disease by helping to extend the effects of levodopa/carbidopa in patients with the condition. It comes as a 200 mg film-coated tablet taken orally. Manufactured by Aurobindo Pharma Ltd. under ANDA203437, it belongs to the class of catechol-O-methyltransferase inhibitors. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Entacapone is a prescription medication used to treat Parkinson's disease by helping to extend the effects of levodopa/carbidopa in patients with the condition. It comes as a 200 mg film-coated tablet taken orally. Manufactured by Aurobindo Pharma Ltd. under ANDA203437, it belongs to the class of catechol-O-methyltransferase inhibitors. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Entacapone",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Entacapone — ANDA 206669 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206669"
}
]
|
| identifier | ANDA206669 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"health-care",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Entacapone |
